Key Takeaways
- • Kirkland & Ellis and Skadden advised on a €29 billion private equity sale, reinforcing both firms' dominant positioning in large-scale M&A and private equity transactions.
- • Kirkland & Ellis continues to lead Big Law's M&A rankings, having served as principal adviser on $829 billion in deal volume, with a 61% year-over-year jump from 2024, demonstrating sustained market dominance in institutional dealmaking.
- • The transaction underscores the scale of institutional private equity activity in 2026, with mega-deals (€25B+) increasingly requiring coordinated counsel from multiple top-tier firms to manage complexity across jurisdictions and stakeholder bases.
- • Kirkland's recent talent acquisitions, including senior biotech and technology partners from competing firms like Skadden, reflect intensifying competition for specialized expertise in high-value deal teams.
Summary
Kirkland & Ellis maintains its commanding position atop Big Law's dealmaking hierarchy. The firm served as principal adviser on $829 billion in M&A transactions, with recent data showing a 61% year-over-year increase from 2024 through the current reporting period. This trajectory positions Kirkland well ahead of competing firms and underscores the firm's sustained penetration across the institutional investor, corporate, and alternative asset management sectors that drive mega-deal volume.
The €29 billion transaction exemplifies the operational scale now required in large PE acquisitions. Contemporary mega-deals of this magnitude typically involve multiple specialized counsel addressing regulatory approvals, financing structures, employment law considerations, and tax optimization across multiple jurisdictions. The pairing of Kirkland and Skadden reflects a strategic allocation of expertise—both firms bring established relationships with institutional PE sponsors and target company stakeholders, along with dedicated teams capable of managing parallel work streams at velocity.
In parallel, Kirkland has been actively recruiting senior talent from competing firms, most notably securing Graham Robinson, a top biotech and technology lawyer, from Skadden. This talent migration underscores the intensifying competition among elite firms for specialized expertise, particularly in technology and life sciences sectors where regulatory and technical complexity commands premium advisory rates. The competitive dynamics in lateral hiring correlate directly with deal flow concentration among market leaders, as premier sponsors increasingly consolidate their work with firms possessing deep sectoral knowledge and proven deal execution capacity.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.